nach oben

Erschienen in:

08.03.2019 | Correspondence

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF^V600E mutation

verfasst von: David W. Ellison, Cynthia Hawkins, David T. W. Jones, Arzu Onar-Thomas, Stefan M. Pfister, Guido Reifenberger, David N. Louis

Erschienen in: Acta Neuropathologica | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Excerpt

Diffuse gliomas occur at all ages, but their incidence is highest among older adults [7]. They have astrocytic or oligodendroglial morphologies and are represented across WHO grades II–IV. In childhood, they are uncommon, presenting less frequently than the broad range of pediatric circumscribed gliomas, particularly pilocytic astrocytoma, and a few glioneuronal tumors, e.g., ganglioglioma [16]. …

Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R et al (2016) MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 48:273–282. https://doi.org/10.1038/ng.3500 CrossRefPubMedPubMedCentral

Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol 136:805–810. https://doi.org/10.1007/s00401-018-1913-0 CrossRefPubMedPubMedCentral

Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M et al (2007) Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25:682–689. https://doi.org/10.1200/JCO.2006.06.8213 CrossRefPubMed

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/nejmoa1402121 CrossRef

Chiang JCH, Harreld JH, Orr BA, Sharma S, Ismail A, Segura AD et al (2017) Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination. Acta Neuropathol 134:159–162. https://doi.org/10.1007/s00401-017-1728-4 CrossRefPubMedPubMedCentral

Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU et al (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol 136:239–253. https://doi.org/10.1007/s00401-018-1865-4 CrossRefPubMed

Ferris SP, Hofmann JW, Solomon DA, Perry A (2017) Characterization of gliomas: from morphology to molecules. Virchows Arch 471:257–269. https://doi.org/10.1007/s00428-017-2181-4 CrossRefPubMed

Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol 14:1265–1284. https://doi.org/10.1093/neuonc/nos202 CrossRefPubMedPubMedCentral

Gupta K, Orisme W, Harreld JH, Qaddoumi I, Dalton JD, Punchihewa C et al (2014) Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups. Acta Neuropathol Commun 2:18. https://doi.org/10.1186/2051-5960-2-18 CrossRefPubMedPubMedCentral

10.

Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J et al (2017) Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist 22:1478–1490. https://doi.org/10.1634/theoncologist.2017-0242 CrossRefPubMedPubMedCentral

11.

Lin FY, Bergstrom K, Person R, Bavle A, Ballester LY, Scollon S et al (2016) Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle. Cold Spring Harb Mol Case Stud 2:a001057. https://doi.org/10.1101/mcs.a001057 CrossRefPubMedPubMedCentral

12.

Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435. https://doi.org/10.1111/bpa.12171 CrossRefPubMedPubMedCentral

13.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1 CrossRefPubMed

14.

Louis DN, Wesseling P, Paulus W, Giannini C, Batchelor TT, Cairncross JG et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135:481–484. https://doi.org/10.1007/s00401-018-1808-0 CrossRefPubMed

15.

Mistry M, Zhukova N, Merico D, Rakopoulos P, Krishnatry R, Shago M et al (2015) BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol 33:1015–1022. https://doi.org/10.1200/JCO.2014.58.3922 CrossRefPubMedPubMedCentral

16.

Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C et al (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol 19:v1–v88. https://doi.org/10.1093/neuonc/nox158 CrossRefPubMedPubMedCentral

17.

Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC et al (2018) The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathol 29:85–96. https://doi.org/10.1111/bpa.12639 CrossRefPubMedPubMedCentral

18.

Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131:833–845. https://doi.org/10.1007/s00401-016-1539-z CrossRefPubMedPubMedCentral

19.

Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE et al (2013) Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci USA 110:8188–8193. https://doi.org/10.1073/pnas.1300252110 CrossRefPubMedPubMedCentral

20.

Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol 136:273–291. https://doi.org/10.1007/s00401-018-1837-8 CrossRefPubMed

21.

Rivera B, Gayden T, Carrot-Zhang J, Nadaf J, Boshari T, Faury D et al (2016) Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 131:847–863. https://doi.org/10.1007/s00401-016-1549-x CrossRefPubMedPubMedCentral

22.

Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 129:609–610. https://doi.org/10.1007/s00401-015-1400-9 CrossRefPubMedPubMedCentral

23.

Smits A, Jakola AS (2019) Clinical presentation, natural history, and prognosis of diffuse low-grade gliomas. Neurosurg Clin N Am 30:35–42. https://doi.org/10.1016/j.nec.2018.08.002 CrossRefPubMed

24.

Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ et al (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol 12:1257–1268. https://doi.org/10.1093/neuonc/noq092 CrossRefPubMedPubMedCentral

25.

Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14:92–107. https://doi.org/10.1038/nrc3655 CrossRefPubMedPubMedCentral

26.

Vaubel RA, Caron AA, Yamada S, Decker PA, Eckel Passow JE, Rodriguez FJ et al (2018) Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation. Brain Pathol 28:172–182. https://doi.org/10.1111/bpa.12495 CrossRefPubMed

27.

Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612. https://doi.org/10.1038/ng.2611 CrossRefPubMedPubMedCentral

Titel: cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
verfasst von: David W. Ellison
Cynthia Hawkins
David T. W. Jones
Arzu Onar-Thomas
Stefan M. Pfister
Guido Reifenberger
David N. Louis
Publikationsdatum: 08.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Acta Neuropathologica / Ausgabe 4/2019
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-019-01987-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF^V600E mutation

Excerpt

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Mission not yet completed: on the ups and downs of being the editor of ANP

TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma

Translational control in brain pathologies: biological significance and therapeutic opportunities

Tau drives translational selectivity by interacting with ribosomal proteins

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie